• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Bone Biologics Corp (BBLG)

Common Shares
Sell: $2.38|Buy: $2.45|Change: 0.03 (-1.01%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

Address




Website

https://www.bonebiologics.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Bone Biologics Corp Second Quarter Earnings Results for 20262026-08-14T00:00:00
Bone Biologics Corp Annual General Meeting for 20262026-05-29T11:00:00
Bone Biologics Corp First Quarter Earnings Results for 20262026-05-12T00:00:00
Bone Biologics Corp Annual Report for 20252026-02-26T00:00:00
Bone Biologics Corp Third Quarter Earnings Results for 20252025-11-14T00:00:00

Previous key dates

NameKey Date
H.C. Wainwright 27th Annual Global Investment Conference2025-09-08T00:00:00
Bone Biologics Corp Second Quarter Earnings Results for 20252025-08-14T00:00:00
Bone Biologics Corp Annual General Meeting for 20252025-05-30T11:00:00
Bone Biologics Corp First Quarter Earnings Results for 20252025-05-12T00:00:00
Bone Biologics Corp Annual Report for 20242025-02-26T00:00:00
Bone Biologics Corp Third Quarter Earnings Results for 20242024-11-14T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.